Cellectar Biosciences (CLRB) Announces One-for-Thirty Reverse Stock Split

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Cellectar Biosciences (CLRB) Announces One-for-Thirty Reverse Stock Split

Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split

June 18, 2025 4:30 PM EDT

FLORHAM PARK, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced a one-for-thirty reverse stock split (the Reverse Stock Split) of the companys common stock, par value $0.00001, which will become effective at 12:01 a.m. Eastern Time on Tuesday, June 24, 2025. The companys common stock will continue to trade under its current trading symbol, CLRB, on the Nasdaq Global Select Market (Nasdaq) on a split-adjusted basis when the market opens on Tuesday, June... More